Skip to main content

Notice

We are in the process of rolling out a soft launch of the RDA website, which includes a new member platform. Existing RDA members PLEASE REACTIVATE YOUR ACCOUNT using this link: https://rda-login.wicketcloud.com/users/confirmation. Visitors may encounter functionality issues with group pages, navigation, missing content, broken links, etc. As you explore the new site, please provide your feedback using the UserSnap tool on the bottom right corner of each page. Thank you for your understanding and support as we work through all issues as quickly as possible. Stay updated about upcoming features and functionalities: https://www.rd-alliance.org/rda-web-platform-upcoming-features-and-functionalities/

RDA P17 submissions

  • Creator
    Discussion
  • #102363

    RDA Admin
    Member

    Hi all, I know I am leaving this a little late in the process, but wanted to check with you all to see if anyone has, or is considering, submitting COVID-19 specific session proposals for P17?
    I was planning to accommodate the COVID-19 WG itself in the context of the emerging Infectious disease Community of Practice, which will be submitted for RDA/broader community review shortly. I am also hoping that there will be a submission for the first meeting of the ID CoP, even though the CoP review process is still underway.
    As a reminder, the deadline is this coming Tuesday, so please let me know via Reply in this thread if you are part if submissions, thanks!
    Mark
    Mark Leggott, Executive Director / Directeur exécutif
    Research Data Canada / Données de recherche Canada
    Co-Chair, Research Data Alliance (RDA) Council
    Chair, CODATA International Data Policy Committee
    Secretary, Canadian National Committee for CODATA (CNC CODATA)
    45 O’Connor Street, Suite 1150 Ottawa, ON K1P 1A4 Canada
    w – rdc-drc.ca t – 613.220.7236 f – 613.943.5443 e – ***@***.***-drc.ca
    Skype – markleggott Twitter – @rdc_drc LinkedIn – ca.linkedin.com/in/markleggott
    ORCID: https://orcid.org/0000-0003-1392-7799
    Book a Meeting with Me – https://doodle.com/mm/markleggott/book-a-time

  • Author
    Replies
  • #129578

    HI Mark,
    My colleagues in the Photon and Neutron facilities (PaNSIG IG) are planning to submit a session proposal on “Sharing FAIR Data on COVID research at Photon and Neutron Facilities”.
    I was in touch with Rob Hooft and we may join up with the ELIXIR Bridging force IG.
    Best
    Juan.
    – Show quoted text -From: ***@***.***-groups.org on behalf of mleggott via RDA COVID19 Coordination
    Sent: 22 January 2021 18:58
    To: RDA COVID-19 Co-Chairs and Moderators
    Subject: [rdacovid19-coordination] RDA P17 submissions
    Hi all, I know I am leaving this a little late in the process, but wanted to check with you all to see if anyone has, or is considering, submitting COVID-19 specific session proposals for P17?
    I was planning to accommodate the COVID-19 WG itself in the context of the emerging Infectious disease Community of Practice, which will be submitted for RDA/broader community review shortly. I am also hoping that there will be a submission for the first meeting of the ID CoP, even though the CoP review process is still underway.
    As a reminder, the deadline is this coming Tuesday, so please let me know via Reply in this thread if you are part if submissions, thanks!
    Mark
    Mark Leggott, Executive Director / Directeur exécutif
    Research Data Canada / Données de recherche Canada
    Co-Chair, Research Data Alliance (RDA) Council
    Chair, CODATA International Data Policy Committee
    Secretary, Canadian National Committee for CODATA (CNC CODATA)
    45 O’Connor Street, Suite 1150 Ottawa, ON K1P 1A4 Canada
    w – rdc-drc.ca t – 613.220.7236 f – 613.943.5443 e – ***@***.***-drc.ca
    Skype – markleggott Twitter – @rdc_drc LinkedIn – ca.linkedin.com/in/markleggott
    ORCID: https://orcid.org/0000-0003-1392-7799
    Book a Meeting with Me – https://doodle.com/mm/markleggott/book-a-time
    This email and any attachments are intended solely for the use of the named recipients. If you are not the intended recipient you must not use, disclose, copy or distribute this email or any of its attachments and should notify the sender immediately and delete this email from your system. UK Research and Innovation (UKRI) has taken every reasonable precaution to minimise risk of this email or any attachments containing viruses or malware but the recipient should carry out its own virus and malware checks before opening the attachments. UKRI does not accept any liability for any losses or damages which the recipient may sustain due to presence of any viruses. Opinions, conclusions or other information in this message and attachments that are not related directly to UKRI business are solely those of the author and do not represent the views of UKRI.

  • #129577

    Hi all,
    We are thinking of proposing something around the work done by the
    Ethical/legal COVID-19 group, but not sure we succeed to be in time aswe
    started late to prepare!.
    Let’s see,
    Anne

  • #129574

    Timea Biro
    Member

    Hi all, Mark,
    I noticed the P17 submissions receipts are coming in, and it just occurred to me that I should have sent a note to the coordination group on a P17 session we submitted related to the summary and community participation papers.
    Most of you know this already, but for everyone else, in case you are interested, you can find the submission text here https://docs.google.com/document/d/1zjW-D16vEhhAKZWC_G7XIl1Q5xhWINIDY4NJ
    We have tagged the COVID-19 WG and related subgroups to avoid conflicts as much as possible.
    Many thanks,
    Timea

    Timea Biro | Project Manager, Digital Repository of Ireland
    Royal Irish Academy | 19 Dawson St. Dublin 2
    ***@***.*** | @dri_ireland | http://www.dri.ie
    From: on behalf of mleggott via RDA COVID19 Coordination
    Reply to: “***@***.***-drc.ca
    Date: Friday 22 January 2021 at 19:00
    To: RDA COVID-19 Co-Chairs and Moderators
    Subject: [rdacovid19-coordination] RDA P17 submissions
    Hi all, I know I am leaving this a little late in the process, but wanted to check with you all to see if anyone has, or is considering, submitting COVID-19 specific session proposals for P17?
    I was planning to accommodate the COVID-19 WG itself in the context of the emerging Infectious disease Community of Practice, which will be submitted for RDA/broader community review shortly. I am also hoping that there will be a submission for the first meeting of the ID CoP, even though the CoP review process is still underway.
    As a reminder, the deadline is this coming Tuesday, so please let me know via Reply in this thread if you are part if submissions, thanks!
    Mark
    Mark Leggott, Executive Director / Directeur exufffdcutif
    Research Data Canada / Donnufffdes de recherche Canada
    Co-Chair, Research Data Alliance (RDA) Council
    Chair, CODATA International Data Policy Committee
    Secretary, Canadian National Committee for CODATA (CNC CODATA)
    45 OufffdConnor Street, Suite 1150 Ottawa, ON K1P 1A4 Canada
    w ufffd rdc-drc.ca t ufffd 613.220.7236 f ufffd 613.943.5443 e ufffd ***@***.***-drc.ca
    Skype ufffd markleggott Twitter ufffd @rdc_drc LinkedIn ufffd ca.linkedin.com/in/markleggott
    ORCID: https://orcid.org/0000-0003-1392-7799
    Book a Meeting with Me – https://doodle.com/mm/markleggott/book-a-time
    The Academy is subject to the FOI Act 2014, the Data Protection Acts 1988-2003 and 2018, GDPR (EU 2016/679) and S.I. No. 336/2011, EC Privacy & Electronic Communications Regulations. For further information see our website http://www.ria.ie/privacy-and-data-protection

Log in to reply.